Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial.

NCT02141035 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02141035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02141035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial.
Lead sponsor
University of Alberta
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2015
Completion date
September 30, 2017
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

carpal tunnel syndrome, compression neuropathy